Learn More
Medchemexpress LLC SRI-37330 (hydrochloride) | 2322245-49-6 | 99.7% | C16H20ClF3N4O2S | 10MG

Supplier: Medchemexpress LLC HY14162310MG
SRI-37330 hydrochloride is an orally bioavailable small-molecule inhibitor of thioredoxin-interacting protein (TXNIP) used in preclinical metabolic research. It modulates glucagon secretion and signaling, reduces hepatic glucose production, and reverses hepatic steatosis, making it relevant for studies of type 2 diabetes and related metabolic disorders.
- Orally bioavailable TXNIP inhibitor.
- Modulates glucagon secretion and function.
- Reduces hepatic glucose production.
- Reverses hepatic steatosis in preclinical models.
- High reported purity (99.72%).
- Solid form suitable for storage and formulation.
- Storage guidance: sealed at 4°C; in solvent, -80°C up to 6 months.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.